MedPath

Early Detection of Lung Cancer With Machine Learning Based on Routine Clinical Investigations

Not yet recruiting
Conditions
Adenocarcinoma of Lung; Bronchial Neoplasms; Early Detection of Cancer; Machine Learning
Interventions
Other: Observational
Registration Number
NCT05907577
Lead Sponsor
The University Clinic of Pulmonary and Allergic Diseases Golnik
Brief Summary

This observational, cross-sectional study in lung cancer patients and lung cancer-free controls aims to develop a machine learning model for early detection of LC based on routine, widely accessible and minimally invasive clinical investigations. The model with adequate predictive performance could later be used in clinical practice as an aid in defining the optimal population and timing for lung cancer screening program.

Detailed Description

Not available

Recruitment & Eligibility

Status
NOT_YET_RECRUITING
Sex
All
Target Recruitment
7500
Inclusion Criteria

Not provided

Exclusion Criteria

Not provided

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Arm && Interventions
GroupInterventionDescription
Disease cohortObservationalObservational, no interventions
Control cohortObservationalObservational, no interventions
Primary Outcome Measures
NameTimeMethod
Develop a model with high predictive performance for early detection of non-small cell lung cancer (NSCLC) in the eligible patient population.11 years

The primary outcome is tested by calculating a joint rectangular 95% confidence region for {sensitivity, specificity} and compared with the reported accuracy of NLST study screening criteria.

Secondary Outcome Measures
NameTimeMethod
Demonstrate that the newly developed model achieves higher prediction accuracy than the well-validated model PLCOm2012.11 years

Trial Locations

Locations (2)

University Clinic of Respiratory and Allergic Diseases Golnik

🇸🇮

Golnik, Slovenia

Jozef Stefan Institute

🇸🇮

Ljubljana, Slovenia

© Copyright 2025. All Rights Reserved by MedPath